Cover Image
市場調查報告書

亞太地區的高濃度血小板血漿 (PRP) 市場 - 產業分析·市場規模·佔有率·成長·趨勢·預測 (2015-2023年)

Platelet Rich Plasma Market (By Type: Pure PRP, Leucocytes & PRP, Platelet Rich Fibrin; By Origin: Autologous PRP, Allogeneic PRP, & Homologous PRP; By Application) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, & Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 352926
出版日期 內容資訊 英文 128 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
亞太地區的高濃度血小板血漿 (PRP) 市場 - 產業分析·市場規模·佔有率·成長·趨勢·預測 (2015-2023年) Platelet Rich Plasma Market (By Type: Pure PRP, Leucocytes & PRP, Platelet Rich Fibrin; By Origin: Autologous PRP, Allogeneic PRP, & Homologous PRP; By Application) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, & Forecast 2015 - 2023
出版日期: 2016年01月27日 內容資訊: 英文 128 Pages
簡介

高濃度血小板血漿 (PRP) 市場可依類型分為純PRP,白血球和PRP,及多血小板纖維蛋白(纖維素)等類別,依來源則可分為自體PRP,同類PRP,及同源PRP。此外高濃度血小板血漿應用於整形外科,美容外科,一般外科,神經外科及其他外科中。

本報告提供亞太地區的高濃度血小板血漿 (PRP) 市場現況與展望調查分析,提供您市場估計實際成果及預測,市場推動與阻礙成長要素分析,彙整各類型·來源別·各用途·各地區的市場分析,以及主要企業簡介。

第1章 序

  • 調查的說明
  • 調查手法
  • 市場區隔

第2章 摘要整理

  • 市場概況

第3章 亞太地區高濃度血小板血漿 (PRP) 市場概要

  • 簡介
  • 價值鏈分析
  • 法規結構
  • 市場動態
    • 推動市場成長要素
    • 阻礙市場成長要素
    • 市場機會
  • 波特的五力分析
  • 亞太地區高濃度血小板血漿 (PRP) 市場市場魅力分析,各國
  • 競爭情形:各主要企業市場佔有率

第4章 亞太地區的高濃度血小板血漿 (PRP) 市場銷售額,各類型

  • 概要
  • 純係高濃度血小板血漿 (P-PRP) 市場銷售額,各國
    • 澳洲
    • 菲律賓
    • 中國
    • 印度
    • 新加坡
    • 泰國
    • 馬來西亞
    • 韓國
    • 香港
    • 台灣
    • 其他APAC (印尼,紐西蘭,越南,其他)
  • 多白血球高濃度血小板血漿 (L-PRP)
  • 純係多血小板纖維蛋白 (纖維本源) (P-PRF) /多白血球多血小板纖維蛋白 (L-PRF)

第5章 亞太地區的高濃度血小板血漿 (PRP) 市場銷售額,來源別

  • 概要
  • 自體高濃度血小板血漿
    • 澳洲
    • 菲律賓
    • 中國
    • 印度
    • 新加坡
    • 泰國
    • 馬來西亞
    • 韓國
    • 香港
    • 台灣
    • 其他APAC (印尼,紐西蘭,越南,其他)
  • 同類高濃度血小板血漿
  • 同源高濃度血小板血漿

第6章 亞太地區的高濃度血小板血漿 (PRP) 市場銷售額,各用途

  • 概要
  • 整形外科
    • 澳洲
    • 菲律賓
    • 中國
    • 印度
    • 新加坡
    • 泰國
    • 馬來西亞
    • 韓國
    • 香港
    • 台灣
    • 其他APAC (印尼,紐西蘭,越南,其他)
  • 美容外科
  • 一般外科
  • 神經外科
  • 其他外科

第7章 亞太地區的高濃度血小板血漿 (PRP) 市場銷售額,各國

  • 概要
  • 澳洲
  • 菲律賓
  • 中國
  • 印度
  • 新加坡
  • 泰國
  • 馬來西亞
  • 韓國
  • 香港
  • 台灣
  • 其他APAC (印尼,紐西蘭,越南,其他)

第8章 建議

第9章 企業簡介

  • AdiStem Ltd.
  • Arthrex, Inc.
  • Biomet, Inc.
  • Cesca Therapeutics, Inc.
  • DePuy Synthes, Inc.
  • Exactech, Inc.
  • Harvest Technologies Corp.
  • NeoGenesis Co. Ltd.
  • Rmedica Co. Ltd.
  • Stryker Corporation
  • Seawon Meditech
目錄

Title: Platelet Rich Plasma Market (By Type: Pure PRP, Leucocytes and PRP, Platelet Rich Fibrin; By Origin: Autologous PRP, Allogeneic PRP, and Homologous PRP; By Application: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Other Surgeries) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.

This report provides a comprehensive analysis of the platelet rich plasma market in Asia Pacific considering various macro as well as microeconomic factors such as regulations, applications of platelet rich plasma, and advantages and disadvantages of type of platelet rich plasma, and cost. The report studies the platelet rich plasma market from four perspectives: type of platelet rich plasma, origin of platelet rich plasma, application of platelet rich plasma, and country wise market.

Based on the type of platelet rich plasma, the market in Asia Pacific has been segmented into pure platelet rich plasma, leucocytes and platelet rich plasma, and platelet rich fibrin. Based on origin, the market has been segmented into autologous platelet rich plasma, allogeneic platelet rich plasma, and homologous platelet rich plasma. In terms of the application of platelet rich plasma, the market has been segmented into orthopedic surgery, cosmetic surgery, general surgery, neurosurgery, and other surgeries. In terms of country, the market has been studied for eleven major geographies: Australia, the Philippines, China, India, Singapore, Thailand, Malaysia, South Korea, Hong Kong, Taiwan, and Rest of Asia Pacific. Additionally, each segment of the platelet rich plasma market has been further subdivided into national markets.

The market size for each of the segments and sub-segments mentioned above is provided in US$ Mn considering 2013 and 2014 as base years and forecast from 2015 to 2023. The forecast model considers various factors such as number of surgeries, health care expenditure of the country, advantages of the individual segment, penetration of platelet rich plasma therapy in the country, the cost of platelet rich plasma in various countries, and government regulations. The research methodology is a blend of primary as well as secondary market research, where market estimates based on desk research are further refined considering inputs from expert interviews.

This report on the platelet rich plasma market in Asia Pacific also provides qualitative information on major players in the market. It also includes details on current regulatory policies for platelet rich plasma and devices. Major factors driving and restraining the platelet rich plasma market are also discussed in the report, while opportunities from the future perspective are also mentioned. Furthermore, the platelet rich plasma market report provides value chain analysis for comprehensive analysis. Porter's Five Forces Analysis will provide the idea of bargaining power of buyers, bargaining power of suppliers, threat of new entrants in platelet rich plasma market, threat of substitutes, and competitive rivalry in platelet rich plasma market. Additionally, market share analysis of the platelet rich plasma market in Asia Pacific provides detailed information on current competitive landscape of the market. Market attractiveness analysis provides information on most attractive countries for platelet rich plasma.

Finally, the report profiles major players in the platelet rich plasma market in Asia Pacific including Harvest Technology, Arthrex, Inc., Stryker Corporation, Zimmer Biomet, DePuy Synthes, AdiStem Ltd., Cesca Therapeutics, Inc., Exactech, Inc., and Rmedica Co. Ltd. Each of the companies is profiled for parameters such as company overview, financial overview, product portfolio, business strategies, and recent developments. The report on the platelet rich plasma market estimation and forecast comprises 128 slides and 68 graphs.

Table of Contents

1. Introduction

  • 1.1. Report Description
  • 1.2. Research Methodology
  • 1.3. Market Segmentation

2. Executive Summary

  • 2.1. Market Snapshot

3. Asia Pacific Platelet Rich Plasma Market Overview

  • 3.1. Introduction
  • 3.2. Value Chain Analysis
  • 3.3. Regulatory Framework
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Porter's Five Force Analysis
    • 3.5.1. Bargaining Power of Buyers
    • 3.5.2. Bargaining Power of Suppliers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Competitive Rivalry
  • 3.6. Market Attractiveness Analysis of the Asia Pacific Platelet Rich Plasma Market, by Country, 2014
  • 3.7. Competitive Landscape: Market Share Analysis by Key Players, 2014(Value, %)

4. Asia Pacific Platelet Rich Plasma Market Revenue, by Type, 2013-2023(US$ Mn)

  • 4.1. Overview
  • 4.2. Pure Platelet-Rich Plasma(P-PRP) Market Revenue, by Country, 2013-2023(US$ Mn)
    • 4.2.1. Australia
    • 4.2.2. Philippines
    • 4.2.3. China
    • 4.2.4. India
    • 4.2.5. Singapore
    • 4.2.6. Thailand
    • 4.2.7. Malaysia
    • 4.2.8. Korea
    • 4.2.9. Hong Kong
    • 4.2.10. Taiwan
    • 4.2.11. Rest of APAC(Indonesia, New Zealand, Vietnam, etc.)
  • 4.3. Leukocyte-Rich Platelet-Rich Plasma(L-PRP)*
  • 4.4. Pure Platelet-Rich Fibrin(P-PRF)/ Leukocyte-Rich Platelet-Rich Fibrin(L-PRF)*

5. Asia Pacific Platelet Rich Plasma Market Revenue, by Origin, 2013-2023(US$ Mn)

  • 5.1. Overview
  • 5.2. Autologous Platelet-Rich Plasma
    • 5.2.1. Australia
    • 5.2.2. Philippines
    • 5.2.3. China
    • 5.2.4. India
    • 5.2.5. Singapore
    • 5.2.6. Thailand
    • 5.2.7. Malaysia
    • 5.2.8. Korea
    • 5.2.9. Hong Kong
    • 5.2.10. Taiwan
    • 5.2.11. Rest of APAC(Indonesia, New Zealand, Vietnam, etc.)
  • 5.3. Allogeneic Platelet-Rich Plasma*
  • 5.4. Homologous Platelet-Rich Plasma*

6. Asia Pacific Platelet Rich Plasma Market Revenue, by Application, 2013-2023(US$ Mn)

  • 6.1. Overview
  • 6.2. Orthopedic Surgery
    • 6.2.1. Australia
    • 6.2.2. Philippines
    • 6.2.3. China
    • 6.2.4. India
    • 6.2.5. Singapore
    • 6.2.6. Thailand
    • 6.2.7. Malaysia
    • 6.2.8. Korea
    • 6.2.9. Hong Kong
    • 6.2.10. Taiwan
    • 6.2.11. Rest of APAC(Indonesia, New Zealand, Vietnam, etc.)
  • 6.3. Cosmetic Surgery*
  • 6.4. General Surgery*
  • 6.5. Neurosurgery*
  • 6.6. Other Surgeries(Urology, Cardiothoracic, Oral & Maxillofacial and Periodontal)*

7. Asia Pacific Platelet Rich Plasma Market Revenue, by Country, 2013-2023(US$ Mn)

  • 7.1. Overview
  • 7.2. Australia
  • 7.3. Philippines
  • 7.4. China
  • 7.5. India
  • 7.6. Singapore
  • 7.7. Thailand
  • 7.8. Malaysia
  • 7.9. Korea
  • 7.10. Hong Kong
  • 7.11. Taiwan
  • 7.12. Rest of APAC(Indonesia, New Zealand, Vietnam, etc.)

8. Recommendations

9. Company Profiles

  • 9.1. AdiStem Ltd.
  • 9.2. Arthrex, Inc.
  • 9.3. Biomet, Inc.
  • 9.4. Cesca Therapeutics, Inc.
  • 9.5. DePuy Synthes, Inc.
  • 9.6. Exactech, Inc.
  • 9.7. Harvest Technologies Corp.
  • 9.8. NeoGenesis Co. Ltd.
  • 9.9. Rmedica Co. Ltd.
  • 9.10. Stryker Corporation
  • 9.11. Seawon Meditech
  • 9.12. Others

*: Similar country wise analysis provided for all other segments.

Back to Top